"ASH 2025: MSD’s B-ALL drug shows potential, but all patients experience AEs" was originally created and published by ...

AMERICAN drugmaker MSD on Wednesday (Oct 5) announced the opening of two manufacturing facilities to produce vaccines and biologics in Singapore. The new factories are part of the US$500 million ...

Let's face it, many problem areas in custom trucks don't rear their ugly heads until the manufacturer has already built hundreds of thousand of trucks and SUVs. For instance, Ford's Coil on Plug (CoP) ...

MSD is reported to have been negotiating with Swiss biotech MoonLake Immunotherapeutics over a takeover deal – estimated to be worth more than $3 billion – according to media reports. The Financial ...

MSD in the Philippines President and Managing Director Andreas Riedel, Vaccines Business Unit Director Ethel Calma, and the ...

MSD and Moderna have kicked off another phase 3 trial of their personalised cancer vaccine V940 used alongside MSD's PD-1 inhibitor Keytruda, this time focusing on patients with earlier-stage ...

ST. LOUIS – Voters in St. Louis City and St. Louis County will decide how the Metropolitan St. Louis Sewer District will pay for required improvements and how it will govern itself moving forward in ...